| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.1 |